Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
CH0038389992
Fri, 21.02.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
February 21, 2025
Annual report of BB Biotech AG as at December 31, 2024
BB Biotech AG publishes its 2024 annual report
BB Biotech AG published its annual report for fiscal year 2024 today. Besides the audited consolidated financial statements, the annual report contains detailed information on the bi [ … ]
Fri, 24.01.2025
BB BIOTECH AG
Ad hoc announcement pursuant to Art. 53 LR
January 24, 2025
BB Biotech AG closes the 2024 fiscal year with a profit
In accordance with regulations on ad hoc publicity, BB Biotech AG (ISIN CH0038389992) is releasing the following information:
Based on its preliminary unaudited consolidated figures, BB Biotech AG reports a profit of approximately [ … ]